NovaBay Pharmaceuticals To Reconvene Special Meeting Of Stockholders To December 18, 2024; Initial Meeting Adjourned Due To Insufficient Votes To Reach The 50% Threshold Of Outstanding Common Shares Voting In Favor Of Proposal One And Two

BenzingaNov 22 16:08 ET

Express News | NovaBay Pharmaceuticals: Iss Supports Co's Proposals to Authorize Sale of Its Avenova Brand

ReutersNov 15 08:01 ET

Prominent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals' Proposals to Authorize the Sale of Its Avenova Brand

BusinesswireNov 15 08:00 ET

NovaBay Pharmaceuticals Reports Q3 2024 Financials Amid Strategic Changes

TipRanksNov 14 23:22 ET

Express News | Ascendiant Capital Maintains Buy on NovaBay Pharmaceuticals, Adjusts Price Target To $0.85 (1-35 Reverse Stock Split)

BenzingaNov 11 12:44 ET

NovaBay GAAP EPS of -$0.60 Misses by $0.30, Revenue of $2.44M Misses by $0.19M

Seeking AlphaNov 8 00:01 ET